DE602005020786D1 - Neuer proteinkomplex und anwendungen davon - Google Patents
Neuer proteinkomplex und anwendungen davonInfo
- Publication number
- DE602005020786D1 DE602005020786D1 DE602005020786T DE602005020786T DE602005020786D1 DE 602005020786 D1 DE602005020786 D1 DE 602005020786D1 DE 602005020786 T DE602005020786 T DE 602005020786T DE 602005020786 T DE602005020786 T DE 602005020786T DE 602005020786 D1 DE602005020786 D1 DE 602005020786D1
- Authority
- DE
- Germany
- Prior art keywords
- amino acid
- acid sequence
- same
- seq
- applications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004165407 | 2004-06-03 | ||
PCT/JP2005/010538 WO2005118631A1 (ja) | 2004-06-03 | 2005-06-02 | 新規タンパク質複合体およびその用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005020786D1 true DE602005020786D1 (de) | 2010-06-02 |
Family
ID=35462884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005020786T Active DE602005020786D1 (de) | 2004-06-03 | 2005-06-02 | Neuer proteinkomplex und anwendungen davon |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090087423A1 (de) |
EP (1) | EP1760087B1 (de) |
JP (1) | JPWO2005118631A1 (de) |
AT (1) | ATE465175T1 (de) |
DE (1) | DE602005020786D1 (de) |
WO (1) | WO2005118631A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5584385B2 (ja) * | 2006-06-02 | 2014-09-03 | 東洋紡株式会社 | ヒトパピローマウイルスの検出法及びタイピング方法 |
US11879000B2 (en) | 2019-11-15 | 2024-01-23 | National Guard Health Affairs | Purification and identification of a protein complex containing b-cell lymphoma protein (BCL10) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000078961A1 (en) | 1999-06-23 | 2000-12-28 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2000012708A2 (en) | 1998-09-01 | 2000-03-09 | Genentech, Inc. | Further pro polypeptides and sequences thereof |
WO2002006329A2 (en) | 2000-07-18 | 2002-01-24 | Curagen Corporation | Human polynucleotides and polypeptides encoded thereby |
WO2002046465A2 (en) | 2000-12-08 | 2002-06-13 | Oxford Biomedica (Uk) Limited | Method for identification of genes involved in specific diseases |
AU2002309583A1 (en) | 2001-04-18 | 2002-11-05 | Protein Desing Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
KR20050085881A (ko) | 2002-12-26 | 2005-08-29 | 다케다 야쿠힌 고교 가부시키가이샤 | 신규 단백질 및 그 용도 |
-
2005
- 2005-06-02 DE DE602005020786T patent/DE602005020786D1/de active Active
- 2005-06-02 EP EP05748510A patent/EP1760087B1/de not_active Not-in-force
- 2005-06-02 AT AT05748510T patent/ATE465175T1/de not_active IP Right Cessation
- 2005-06-02 US US11/628,410 patent/US20090087423A1/en not_active Abandoned
- 2005-06-02 WO PCT/JP2005/010538 patent/WO2005118631A1/ja active Application Filing
- 2005-06-02 JP JP2006514156A patent/JPWO2005118631A1/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1760087A4 (de) | 2007-07-11 |
JPWO2005118631A1 (ja) | 2008-05-29 |
WO2005118631A1 (ja) | 2005-12-15 |
ATE465175T1 (de) | 2010-05-15 |
EP1760087A1 (de) | 2007-03-07 |
EP1760087B1 (de) | 2010-04-21 |
US20090087423A1 (en) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE361067T1 (de) | Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen | |
DE602004011511D1 (de) | N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulphonyl)phenylalanin derivate und verwandte verbindungen zur behandlung von diabetes | |
ATE353880T1 (de) | Neue verwendung von pyrimidin- oder triazin-2- carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2- carbonsäurenitrilderivate | |
BRPI0417101A (pt) | uso de compostos de peptìdeo para tratamento de dor neuropática central | |
EP1302542A4 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
WO2006087550A8 (en) | Amyloid-binding peptides, analogues and uses thereof | |
WO2004078777A3 (en) | Dipeptidyl-peptidase protected proteins | |
DE602005022113D1 (de) | Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
MX2009005622A (es) | Dihidro-imidazoles sustituidos y su uso en el tratamiento de tumores. | |
WO2006019982A3 (en) | Pin1-modulating compounds and methods of use thereof | |
ATE506957T1 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
CY1109975T1 (el) | Παρα-αλκυλ-υποκατεστημενα αμιδια ν-(4-υδροξυ-3-μεθοξυ-βενζυλο) κιναμμωμικου οξεος και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
ATE399758T1 (de) | Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten | |
BRPI0415781A (pt) | método para o tratamento de diabetes em um paciente e kit farmacêutico | |
ATE457727T1 (de) | Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen | |
ATE465175T1 (de) | Neuer proteinkomplex und anwendungen davon | |
DE602005007471D1 (de) | Satraplatin zur behandlung von resistenten oder refrkatären tumoren | |
DE602004016006D1 (de) | Screening-verfahren | |
ATE485831T1 (de) | Behandlung von neurodegeneration | |
ATE464564T1 (de) | Screening-verfahren | |
ATE397753T1 (de) | Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung | |
BR0308911A (pt) | Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |